Importer of Controlled Substances Application: Research Triangle Institute, 23044-23049 [2024-07037]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
23044
Federal Register / Vol. 89, No. 65 / Wednesday, April 3, 2024 / Notices
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
Pathenia M. Proctor, The Office of
Unfair Import Investigations, U.S.
International Trade Commission,
telephone (202) 205–2560.
SUPPLEMENTARY INFORMATION:
Authority: The authority for
institution of this investigation is
contained in section 337 of the Tariff
Act of 1930, as amended, 19 U.S.C.
1337, and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2023).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
March 29, 2024, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain products
identified in paragraph (2) by reason of
infringement of one or more of claims
1–5, 7, 11, 12, 14, 15, 17, 18, 20, 39, and
40 of the ’540 patent and claims 1–5, 7,
11, 12, 14, 15, 17, 18, and 20 of the ’059
patent, and whether an industry in the
United States exists as required by
subsection (a)(2) of section 337;
(2) Pursuant to section 210.10(b)(1) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(1), the
plain language description of the
accused products or category of accused
products, which defines the scope of the
investigation, is ‘‘sacral
neuromodulation systems to control
neurostimulators surgically implanted
into a human patient, incorporating
medical programmers and printed
circuit boards used in same’’;
(3) Pursuant to Commission Rule
210.50(b)(1), 19 CFR 210.50(b)(1), the
presiding administrative law judge shall
take evidence or other information and
hear arguments from the parties or other
interested persons with respect to the
public interest in this investigation, as
appropriate, and provide the
Commission with findings of fact and a
recommended determination on this
issue, which shall be limited to the
statutory public interest factors set forth
in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1);
(4) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are:
VerDate Sep<11>2014
18:18 Apr 02, 2024
Jkt 262001
Medtronic, Inc., 710 Medtronic
Parkway, Minneapolis, MN 55432
Medtronic Logistics, LLC, 710
Medtronic Parkway, Minneapolis, MN
55432
Medtronic USA, Inc., 710 Medtronic
Parkway, Minneapolis, MN 55432
Medtronic Puerto Rico Operations Co.,
Ceiba Norte Industrial Park, 50 Road
31, Km. 24.4, Juncos, Puerto Rico
00777
(b) The respondent is the following
entity alleged to be in violation of
section 337, and is the party upon
which the complaint is to be served:
Axonics, Inc., 26 Technology Drive,
Irvine, CA 92618
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW, Suite
401, Washington, DC 20436; and
(5) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondent in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15798 (March 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainants of
the complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of the respondent to file a
timely response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: March 29, 2024.
Katherine Hiner,
Supervisory Attorney.
[FR Doc. 2024–07068 Filed 4–2–24; 8:45 am]
BILLING CODE 7020–02–P
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1347]
Importer of Controlled Substances
Application: Research Triangle
Institute
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Research Triangle Institute
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 3, 2024. Such persons
may also file a written request for a
hearing on the application on or before
May 3, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on March 11, 2024,
Research Triangle Institute, 3040 East
Cornwallis Road, Hermann Building,
Room 106, Research Triangle Park,
North Carolina 27709–2194, applied to
SUMMARY:
E:\FR\FM\03APN1.SGM
03APN1
23045
Federal Register / Vol. 89, No. 65 / Wednesday, April 3, 2024 / Notices
be registered as an importer of the
following basic class(es) of controlled
substance(s):
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Drug code
Amineptine (7-[(10,11-dihydro-5Hdibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) .......................................................
Mesocarb (N-phenyl-N′-(3-(1-phenylpropan-2-yl)-1,2,3- oxadiazol-3-ium-5-yl)carbamimidate) ............................................
3-Fluoro-N-methylcathinone (3-FMC) ....................................................................................................................................
Cathinone ..............................................................................................................................................................................
Methcathinone .......................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) 1238 I N ....................................................................................................................
Para-Methoxymethamphetamine (PMMA), 1-(4- methoxyphenyl)-N-methylpropan-2-amine ...............................................
Pentedrone (a-methylaminovalerophenone) .........................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ..........................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ......................................................................................................................................
Naphyrone .............................................................................................................................................................................
3-methylmethcathinone (2-(methylamino)-1-(3- methylphenyl)propan-1-one) ......................................................................
N-Ethylamphetamine .............................................................................................................................................................
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- amine) 1478 I N ............................................................................
N,N-Dimethylamphetamine ....................................................................................................................................................
Fenethylline ...........................................................................................................................................................................
Aminorex ................................................................................................................................................................................
4-Methylaminorex (cis isomer) ..............................................................................................................................................
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- 1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine).
Gamma Hydroxybutyric Acid .................................................................................................................................................
Methaqualone ........................................................................................................................................................................
Mecloqualone ........................................................................................................................................................................
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6Hthieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine .......................................
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) ..................................
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine .........................................
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine .................................
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one .....................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .........................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .......................................................
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .......................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............................
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) .....................................................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................................
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .............................
FUB-AMB, MMB- FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ..
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................................
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .......................................................................
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ...............................
ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan 2-yl)-1-butyl-1H-indazole-3-carboxamide) .....................................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ......................
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ...............
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .....................................................
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..............
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ........................................
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .................................
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ......................................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)
4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2- (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate) 7043 I N.
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ...............
FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ..................................................................
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ..........................................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .........................................................................................................
5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ............................
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) .......................
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-(4cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).
MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4- en-1-yl)-1H-indazole-3-carboxamido)butanoate) 7090 I N
MDMB-4en-PINACA.
4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate .....................................
ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1- oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3- carboxamide) ...............
CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2- yl)pyrido[4,3-b]indol-1-one) ............................................................
5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate .........................................
MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole3-carboxamido)-3-methyl butanoate ...............................................
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ...........................................................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ....................................................................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................................
VerDate Sep<11>2014
18:18 Apr 02, 2024
Jkt 262001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\03APN1.SGM
03APN1
Schedule
1219
1227
1233
1235
1237
1238
1245
1246
1248
1249
1258
1259
1475
1478
1480
1503
1585
1590
1595
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
2010
2565
2572
2780
2785
2786
2788
2789
6250
7008
7010
7011
7012
7014
7019
7020
7021
7023
7024
7025
7027
7031
7032
7033
7034
7035
7036
7041
7042
7043
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7044
7047
I
I
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
7090
I
7091
7092
7093
7094
7095
7104
7118
7122
I
I
I
I
I
I
I
I
23046
Federal Register / Vol. 89, No. 65 / Wednesday, April 3, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Drug code
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ........................................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ..............................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) .............................................................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ............................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate ................................................................
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ........................................................................................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ....................................................................................
4-methyl-alpha-ethylaminopentiophenone (4-MEAP) 7245 I N 4-MEAP ..............................................................................
N-ethylhexedrone 7246 I N ...................................................................................................................................................
Alpha-ethyltryptamine ............................................................................................................................................................
Ibogaine .................................................................................................................................................................................
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine) .............................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .......................................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .................................................
Lysergic acid diethylamide ....................................................................................................................................................
2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine .......................................................................................................
Marihuana Extract .................................................................................................................................................................
Parahexyl ...............................................................................................................................................................................
Mescaline ...............................................................................................................................................................................
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) ..................................................................................................
3,4,5-Trimethoxyamphetamine ..............................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ...................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ...................................................................................................................................
2,5-Dimethoxyamphetamine ..................................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ............................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ......................................................................................................................................
3,4-Methylenedioxyamphetamine ..........................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ........................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ........................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .............................................................................................................................
3,4-Methylenedioxymethamphetamine ..................................................................................................................................
4-Methoxyamphetamine ........................................................................................................................................................
Peyote ....................................................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .......................................................................................................................................
Alpha-methyltryptamine .........................................................................................................................................................
Bufotenine ..............................................................................................................................................................................
Diethyltryptamine ...................................................................................................................................................................
Dimethyltryptamine ................................................................................................................................................................
Psilocybin ...............................................................................................................................................................................
Psilocyn .................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ...................................................................................................................................
4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-aPV .......................................................................................................
4′-methyl-alpha-pyrrolidinohexiophenone (MPHP .................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ..........................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ..........................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .....................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ....................................................................................................................................
N-Ethyl-3-piperidyl benzilate ..................................................................................................................................................
N-Methyl-3-piperidyl benzilate ...............................................................................................................................................
N-Benzylpiperazine ................................................................................................................................................................
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ...........................................................................................................
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ........................................................................................................
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ............................................................................................................
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) .........................................................................................................................
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ................................................................................................................
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ..........................................................................................................
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ...........................................................................................................
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ....................................................................................................
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ...........................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .............................................................................................................................
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ...........................................................
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ...........................................................
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ............................................................................................................
Butylone .................................................................................................................................................................................
Pentylone ...............................................................................................................................................................................
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ...........................................................
alpha-pyrrolidinohexanophenone (a-PHP) ............................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ..............................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ................................................................................................................................
Ethylone .................................................................................................................................................................................
alpha-pyrrolidinoheptaphenone (PV8) ...................................................................................................................................
VerDate Sep<11>2014
18:18 Apr 02, 2024
Jkt 262001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
E:\FR\FM\03APN1.SGM
03APN1
7144
7173
7200
7201
7203
7221
7222
7225
7245
7246
7249
7260
7286
7297
7298
7315
7348
7350
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7415
7431
7432
7433
7434
7435
7437
7438
7439
7443
7446
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7547
7548
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
23047
Federal Register / Vol. 89, No. 65 / Wednesday, April 3, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Drug code
Eutylone .................................................................................................................................................................................
a-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1- one) ................................................................................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ..........................................................................................................
Acetyldihydrocodeine .............................................................................................................................................................
Benzylmorphine .....................................................................................................................................................................
Codeine-N-oxide ....................................................................................................................................................................
Cyprenorphine .......................................................................................................................................................................
Desomorphine .......................................................................................................................................................................
Etorphine (except HCl) ..........................................................................................................................................................
Codeine methylbromide .........................................................................................................................................................
Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-4l)1,3-dihydro-2H-benzo[d]imidazol-2-one) ........................................
Dihydromorphine ...................................................................................................................................................................
Difenoxin ................................................................................................................................................................................
Heroin ....................................................................................................................................................................................
Hydromorphinol .....................................................................................................................................................................
Methyldesorphine ..................................................................................................................................................................
Methyldihydromorphine .........................................................................................................................................................
Morphine methylbromide .......................................................................................................................................................
Morphine methylsulfonate .....................................................................................................................................................
Morphine-N-oxide ..................................................................................................................................................................
Myrophine ..............................................................................................................................................................................
Nicocodeine ...........................................................................................................................................................................
Nicomorphine .........................................................................................................................................................................
Normorphine ..........................................................................................................................................................................
Pholcodine .............................................................................................................................................................................
Thebacon ...............................................................................................................................................................................
Acetorphine ............................................................................................................................................................................
Drotebanol .............................................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .....................................................................
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ........................................................................
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .........................................................................................................
Acetylmethadol ......................................................................................................................................................................
Allylprodine ............................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ............................................................................................................
Alphameprodine .....................................................................................................................................................................
Alphamethadol .......................................................................................................................................................................
Benzethidine ..........................................................................................................................................................................
Betacetylmethadol .................................................................................................................................................................
Betameprodine ......................................................................................................................................................................
Betamethadol .........................................................................................................................................................................
Betaprodine ...........................................................................................................................................................................
Clonitazene ............................................................................................................................................................................
Dextromoramide ....................................................................................................................................................................
Isotonotazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) ..................................
Diampromide .........................................................................................................................................................................
Diethylthiambutene ................................................................................................................................................................
Dimenoxadol ..........................................................................................................................................................................
Dimepheptanol .......................................................................................................................................................................
Dimethylthiambutene .............................................................................................................................................................
Dioxaphetyl butyrate ..............................................................................................................................................................
Dipipanone .............................................................................................................................................................................
Ethylmethylthiambutene ........................................................................................................................................................
Etonitazene ............................................................................................................................................................................
Etoxeridine .............................................................................................................................................................................
Furethidine .............................................................................................................................................................................
Hydroxypethidine ...................................................................................................................................................................
Ketobemidone ........................................................................................................................................................................
Levomoramide .......................................................................................................................................................................
Levophenacylmorphan ..........................................................................................................................................................
Morpheridine ..........................................................................................................................................................................
Noracymethadol .....................................................................................................................................................................
Norlevorphanol ......................................................................................................................................................................
Normethadone .......................................................................................................................................................................
Norpipanone ..........................................................................................................................................................................
Phenadoxone .........................................................................................................................................................................
Phenampromide ....................................................................................................................................................................
Phenoperidine ........................................................................................................................................................................
Piritramide ..............................................................................................................................................................................
Proheptazine ..........................................................................................................................................................................
Properidine ............................................................................................................................................................................
Racemoramide ......................................................................................................................................................................
Trimeperidine .........................................................................................................................................................................
Phenomorphan ......................................................................................................................................................................
Propiram ................................................................................................................................................................................
VerDate Sep<11>2014
18:18 Apr 02, 2024
Jkt 262001
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
E:\FR\FM\03APN1.SGM
03APN1
7549
7551
7694
9051
9052
9053
9054
9055
9056
9070
9098
9145
9168
9200
9301
9302
9304
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9547
9551
9560
9601
9602
9603
9604
9605
9606
9607
9608
9609
9611
9612
9613
9614
9615
9616
9617
9618
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
23048
Federal Register / Vol. 89, No. 65 / Wednesday, April 3, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Drug code
1-Methyl-4-phenyl-4-propionoxypiperidine ............................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ....................................................................................................................
Tilidine ...................................................................................................................................................................................
Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)-N,N-diethylethan-1-amine) ...........................................
lunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5- nitro1H-benzimidazol-1-yl)ethan-1- amine) ...............................................
Metonitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-5- nitro-1Hbenzimidazol-1-yl)ethan-1-amine .......................................
N-pyrrolidino etonitazene; etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)- 1Hbenzimidazole) ........
Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine) ....................................
Metodesnitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)- 1H-benzimidazol-1- yl)ethan-1-amine) .........................................
Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)- 1Hbenzimidazol-1-yl)-N,N-diethylethan-1- amine) ..................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .......................................................................................
Para-Fluorofentanyl ...............................................................................................................................................................
3-Methylfentanyl ....................................................................................................................................................................
Alpha-methylfentanyl .............................................................................................................................................................
Acetyl-alpha-methylfentanyl ...................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide .............................................................................................
Para-Methylfentanyl (N-(4-methylphenyl)-N-(1- phenethylpiperidin-4-yl)propionamide; also known as 4- methylfentanyl)
4′-Methyl acetyl fentanyl (N-(1-(4- methylphenethyl)piperidin-4-yl)-N-phenylacetamide) .....................................................
ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) ................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .....................................................................................
Butyryl Fentanyl .....................................................................................................................................................................
Para-fluorobutyryl fentanyl .....................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ...............................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ...............................................................................................
Para-chloroisobutyryl fentanyl ...............................................................................................................................................
Isobutyryl fentanyl ..................................................................................................................................................................
Beta-hydroxyfentanyl .............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ..............................................................................................................................................
Alpha-methylthiofentanyl .......................................................................................................................................................
3-Methylthiofentanyl ...............................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ...................................................................
Thiofentanyl ...........................................................................................................................................................................
Beta-hydroxythiofentanyl .......................................................................................................................................................
Para-methoxybutyryl fentanyl ................................................................................................................................................
Ocfentanil ...............................................................................................................................................................................
Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylthiophene-2-carboxamide; also known as 2- thiofuranyl
fentanyl; thiophene fentanyl).
Valeryl fentanyl ......................................................................................................................................................................
Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylbenzamide; also known as benzoyl fentanyl) ................................
beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- diphenylpropanamide; also known as b′-phenyl fentanyl; 3phenylpropanoyl fentanyl).
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ................................................................................
Crotonyl fentanyl ((E-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) .......................................................................
Cyclopropyl Fentanyl .............................................................................................................................................................
ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)butyramide; also known as 2- fluorobutyryl
fentanyl).
Cyclopentyl fentanyl ..............................................................................................................................................................
ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl)acetamide; also known as 2- methyl
acetylfentanyl).
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ...........................................................................................
Fentanyl carbamate (ethyl (1-phenethylpiperidin-4- yl)(phenyl)carbamate) .........................................................................
ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)acrylamide) ....................................................
ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide) .......................................
Para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)furan-2-carboxamide) ................................
2′-Fluoro ortho-fluorofentanyl (N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as
2′-fluoro 2- fluorofentanyl).
beta-Methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl)propionamide; also known as b-methyl fentanyl) ......
meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)propionamide) ........................................................
meta-Fluoroisobutylryl fentanyl (N-(3-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide) .......................................
para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N- (1-phenethylpiperidin-4-yl)furan-2-carboxamide) ..........................
3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylfuran-3-carboxamide) .................................................................
2′,5′-Dimethoxyfentanyl (N-(1-(2,5- dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) ........................................
Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4- yl)-N-phenylbutanamide) ..............................................................
ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)furan-2-carboxamide) .................................
alpha′Methyl butyryl fentanyl (2-methyl-N-(1- phenethylpiperidin-4-yl)-N-phenylbutanamide) .............................................
para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N- (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) .................
Zipeprol (1-methoxy-3[-4-(2-methoxy-2- phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) ..................................................
Phenmetrazine .......................................................................................................................................................................
Methylphenidate ....................................................................................................................................................................
Amobarbital ............................................................................................................................................................................
Pentobarbital ..........................................................................................................................................................................
Secobarbital ...........................................................................................................................................................................
Glutethimide ...........................................................................................................................................................................
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration .......
VerDate Sep<11>2014
18:18 Apr 02, 2024
Jkt 262001
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
E:\FR\FM\03APN1.SGM
03APN1
Schedule
9661
9663
9750
9751
9756
9757
9758
9759
9764
9765
9811
9812
9813
9814
9815
9816
9817
9819
9820
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9839
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
9840
9841
9842
I
I
I
9843
9844
9845
9846
I
I
I
I
9847
9848
I
I
9850
9851
9852
9853
9854
9855
I
I
I
I
I
I
9856
9857
9858
9859
9860
9861
9862
9863
9864
9865
9873
1631
1724
2125
2270
2315
2550
7365
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
23049
Federal Register / Vol. 89, No. 65 / Wednesday, April 3, 2024 / Notices
Controlled substance
Drug code
lotter on DSK11XQN23PROD with NOTICES1
Nabilone .................................................................................................................................................................................
1-Phenylcyclohexylamine ......................................................................................................................................................
Phencyclidine .........................................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) ...........................................................................................................................
Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) .......................................................................................................
Phenylacetone .......................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ......................................................................................................................................
Alphaprodine ..........................................................................................................................................................................
Anileridine ..............................................................................................................................................................................
Coca Leaves ..........................................................................................................................................................................
Cocaine ..................................................................................................................................................................................
Etorphine HCl ........................................................................................................................................................................
Dihydrocodeine ......................................................................................................................................................................
Diphenoxylate ........................................................................................................................................................................
Ecgonine ................................................................................................................................................................................
Ethylmorphine ........................................................................................................................................................................
Levomethorphan ....................................................................................................................................................................
Levorphanol ...........................................................................................................................................................................
Isomethadone ........................................................................................................................................................................
Meperidine .............................................................................................................................................................................
Meperidine intermediate-A ....................................................................................................................................................
Meperidine intermediate-B ....................................................................................................................................................
Meperidine intermediate-C ....................................................................................................................................................
Metazocine ............................................................................................................................................................................
Oliceridine (N-[(3-methoxythiophen-2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-oxaspiro[4.5] decan-9-yl] ethyl {time})amine fumarate).
Metopon .................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ....................................................................................................................
Dihydroetorphine ...................................................................................................................................................................
Opium tincture .......................................................................................................................................................................
Opium, powdered ..................................................................................................................................................................
Opium, granulated .................................................................................................................................................................
Noroxymorphone ...................................................................................................................................................................
Phenazocine ..........................................................................................................................................................................
Thiafentanil ............................................................................................................................................................................
Piminodine .............................................................................................................................................................................
Racemethorphan ...................................................................................................................................................................
Racemorphan ........................................................................................................................................................................
Alfentanil ................................................................................................................................................................................
Remifentanil ...........................................................................................................................................................................
Sufentanil ...............................................................................................................................................................................
Carfentanil .............................................................................................................................................................................
Tapentadol .............................................................................................................................................................................
Bezitramide ............................................................................................................................................................................
Moramide-intermediate ..........................................................................................................................................................
The company plans to import small
quantities of the listed controlled
substances to support research activities
funded by the National Institute on Drug
Abuse. No other activities for these drug
codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–07037 Filed 4–2–24; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
18:18 Apr 02, 2024
Jkt 262001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1339]
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Purisys, LLC has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
DATES:
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
7379
7460
7471
8333
8366
8501
8603
9010
9020
9040
9041
9059
9120
9170
9180
9190
9210
9220
9226
9230
9232
9233
9234
9240
9245
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
9260
9273
9334
9630
9639
9640
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9802
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
on or before May 3, 2024. Such persons
may also file a written request for a
hearing on the application on or before
May 3, 2024.
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
ADDRESSES:
Importer of Controlled Substances
Application: Purisys, LLC
Schedule
E:\FR\FM\03APN1.SGM
03APN1
]]>Agencies
[Federal Register Volume 89, Number 65 (Wednesday, April 3, 2024)]
[Notices]
[Pages 23044-23049]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07037]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1347]
Importer of Controlled Substances Application: Research Triangle
Institute
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Research Triangle Institute has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
May 3, 2024. Such persons may also file a written request for a hearing
on the application on or before May 3, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 11, 2024, Research Triangle Institute, 3040
East Cornwallis Road, Hermann Building, Room 106, Research Triangle
Park, North Carolina 27709-2194, applied to
[[Page 23045]]
be registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Amineptine (7-[(10,11-dihydro- 1219 I
5Hdibenzo[a,d]cyclohepten-5-
yl)amino]heptanoic acid).
Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2- 1227 I
yl)-1,2,3- oxadiazol-3-ium-5-
yl)carbamimidate).
3-Fluoro-N-methylcathinone (3-FMC)......... 1233 I
Cathinone.................................. 1235 I
Methcathinone.............................. 1237 I
4-Fluoro-N-methylcathinone (4-FMC) 1238 I N 1238 I
Para-Methoxymethamphetamine (PMMA), 1-(4- 1245 I
methoxyphenyl)-N-methylpropan-2-amine.
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone).... 1248 I
4-Methyl-N-ethylcathinone (4-MEC).......... 1249 I
Naphyrone.................................. 1258 I
3-methylmethcathinone (2-(methylamino)-1-(3- 1259 I
methylphenyl)propan-1-one).
N-Ethylamphetamine......................... 1475 I
Methiopropamine (N-methyl-1-(thiophen-2- 1478 I
yl)propan-2- amine) 1478 I N.
N,N-Dimethylamphetamine.................... 1480 I
Fenethylline............................... 1503 I
Aminorex................................... 1585 I
4-Methylaminorex (cis isomer).............. 1590 I
4,4'-Dimethylaminorex (4,4'-DMAR; 4,5- 1595 I
dihydro-4- 1595 I N methyl-5-(4-
methylphenyl)-2-oxazolamine; 4-methyl-5-
(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-
amine).
Gamma Hydroxybutyric Acid.................. 2010 I
Methaqualone............................... 2565 I
Mecloqualone............................... 2572 I
Etizolam (4-(2-chlorophenyl)-2-ethyl-9- 2780 I
methyl-6Hthieno[3,2-f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Flualprazolam (8-chloro-6-(2-fluorophenyl)- 2785 I
1-methyl-4Hbenzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine).
Clonazolam (6-(2-chlorophenyl)-1-methyl-8- 2786 I
nitro-4Hbenzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1- 2788 I
methyl4H-benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Diclazepam (7-chloro-5-(2-chloro-5-(2- 2789 I
chlorophenyl)-1- methyl-1,3-dihydro-2H-
benzo[e][1,4]diazepin-2-one.
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) 6250 I
indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-methoxyphenylacetyl)
indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1- 7010 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- 7012 I
2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3- 7014 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).... 7019 I
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)- 7020 I
1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate).
FUB-AMB, MMB- FUBINACA, AMB-FUBINACA (2-(1- 7021 I
(4-fluorobenzyl)-1Hindazole-3-carboxamido)-
3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7023 I
yl)-1-pentyl-1H-indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone).
5F-AB-PINACA (N-(1-amino-3-methyl-1- 7025 I
oxobutan-2-yl)-1-(5-fluropentyl)-1H-
indazole-3-carboximide).
ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1- 7027 I
oxobutan 2-yl)-1-butyl-1H-indazole-3-
carboxamide).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan- 7031 I
2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033 I
indazole-3-carboxamido)-3-methylbutanoate).
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5- 7034 I
fluoropentyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)- 7036 I
1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)- 7041 I
1H-indole-3-carboxamido)-3,3-
dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate).
4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 7043 I
2- (1-(4-fluorobutyl)-1H-indazole-3-
carboxamido)-3,3- dimethylbutanoate) 7043
I N.
MMB-CHMICA, AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3-methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N-(4- 7047 I
FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl- 7048 I
1H-indazole-3-carboxamide).
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1- 7049 I
(5-fluoropentyl)-1H-indazole-3-
carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) 7081 I
indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)- 7083 I
N-(2-phenylpropan-2-yl)-1H-indazole-3-
carboxamide).
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I
phenylpropan-2-yl)-1H-pyrrolo[2,3-
b]pyridine-3-carboxamide).
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 7089 I
4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-
78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-
yl)-1H-indazole-3-carboxamide).
MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1- 7090 I
(pent-4- en-1-yl)-1H-indazole-3-
carboxamido)butanoate) 7090 I N MDMB-4en-
PINACA.
4F-MDMB-BUTICA (methyl 2-[[1-(4- 7091 I
fluorobutyl)indole-3- carbonyl]amino]-3,3-
dimethyl-butanoate.
ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1- 7092 I
oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-
indazole-3- carboxamide).
CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan- 7093 I
2- yl)pyrido[4,3-b]indol-1-one).
5F-EDMB-PICA (ethyl 2-[[1-(5- 7094 I
fluorophentyl)indole-3- carbonyl]amino]-
3,3-dimethyl-butanoate.
MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H- 7095 I
indole3-carboxamido)-3-methyl butanoate.
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- 7104 I
methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3- 7118 I
(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) 7122 I
indole).
[[Page 23046]]
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).... 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) 7201 I
indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) 7203 I
indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5- 7221 I
fluoropentyl)-1H-indole-3-carboxylate.
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- 7225 I
1H-indole-3-carboxylate).
4-methyl-alpha-ethylaminopentiophenone (4- 7245 I
MEAP) 7245 I N 4-MEAP.
N-ethylhexedrone 7246 I N.................. 7246 I
Alpha-ethyltryptamine...................... 7249 I
Ibogaine................................... 7260 I
2-(ethylamino)-2-(3- 7286 I
methoxyphenyl)cyclohexan-1-one
(methoxetamine).
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide................. 7315 I
2C-T-7 (2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine.
Marihuana Extract.......................... 7350 I
Parahexyl.................................. 7374 I
Mescaline.................................. 7381 I
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine ).
3,4,5-Trimethoxyamphetamine................ 7390 I
4-Bromo-2,5-dimethoxyamphetamine........... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine........ 7392 I
4-Methyl-2,5-dimethoxyamphetamine.......... 7395 I
2,5-Dimethoxyamphetamine................... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) 7398 I
indole).
2,5-Dimethoxy-4-ethylamphetamine........... 7399 I
3,4-Methylenedioxyamphetamine.............. 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine.... 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine.... 7402 I
3,4-Methylenedioxy-N-ethylamphetamine...... 7404 I
3,4-Methylenedioxymethamphetamine.......... 7405 I
4-Methoxyamphetamine....................... 7411 I
Peyote..................................... 7415 I
5-Methoxy-N-N-dimethyltryptamine........... 7431 I
Alpha-methyltryptamine..................... 7432 I
Bufotenine................................. 7433 I
Diethyltryptamine.......................... 7434 I
Dimethyltryptamine......................... 7435 I
Psilocybin................................. 7437 I
Psilocyn................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine........ 7439 I
4-chloro-alpha-pyrrolidinovalerophenone (4- 7443 I
chloro-aPV.
4'-methyl-alpha-pyrrolidinohexiophenone 7446 I
(MPHP.
N-Ethyl-1-phenylcyclohexylamine............ 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine.......... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine...... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine..... 7473 I
N-Ethyl-3-piperidyl benzilate.............. 7482 I
N-Methyl-3-piperidyl benzilate............. 7484 I
N-Benzylpiperazine......................... 7493 I
4-MePPP (4-Methyl- 7498 I
alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine).
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine)... 7517 I
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine).
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)...... 7535 I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)- 7536 I
N-(2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)- 7537 I
N-(2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N- 7538 I
(2-methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone................................... 7541 I
Pentylone.................................. 7542 I
N-Ethypentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-pentan-1-
one).
alpha-pyrrolidinohexanophenone (a-PHP)..... 7544 I
alpha-pyrrolidinopentiophenone ([alpha]- 7545 I
PVP).
alpha-pyrrolidinobutiophenone ([alpha]-PBP) 7546 I
Ethylone................................... 7547 I
alpha-pyrrolidinoheptaphenone (PV8)........ 7548 I
[[Page 23047]]
Eutylone................................... 7549 I
[alpha]-PiHP (4-methyl-1-phenyl-2- 7551 I
(pyrrolidin-1-yl)pentan-1- one).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Acetyldihydrocodeine....................... 9051 I
Benzylmorphine............................. 9052 I
Codeine-N-oxide............................ 9053 I
Cyprenorphine.............................. 9054 I
Desomorphine............................... 9055 I
Etorphine (except HCl)..................... 9056 I
Codeine methylbromide...................... 9070 I
Brorphine (1-(1-(1-(4- 9098 I
bromophenyl)ethyl)piperidin-4-4l)1,3-
dihydro-2H-benzo[d]imidazol-2-one).
Dihydromorphine............................ 9145 I
Difenoxin.................................. 9168 I
Heroin..................................... 9200 I
Hydromorphinol............................. 9301 I
Methyldesorphine........................... 9302 I
Methyldihydromorphine...................... 9304 I
Morphine methylbromide..................... 9305 I
Morphine methylsulfonate................... 9306 I
Morphine-N-oxide........................... 9307 I
Myrophine.................................. 9308 I
Nicocodeine................................ 9309 I
Nicomorphine............................... 9312 I
Normorphine................................ 9313 I
Pholcodine................................. 9314 I
Thebacon................................... 9315 I
Acetorphine................................ 9319 I
Drotebanol................................. 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol............................. 9601 I
Allylprodine............................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine............................. 9604 I
Alphamethadol.............................. 9605 I
Benzethidine............................... 9606 I
Betacetylmethadol.......................... 9607 I
Betameprodine.............................. 9608 I
Betamethadol............................... 9609 I
Betaprodine................................ 9611 I
Clonitazene................................ 9612 I
Dextromoramide............................. 9613 I
Isotonotazene (N,N-diethyl-2-(2-(4 9614 I
isopropoxybenzyl)-5-nitro-1H-benzimidazol-
1-yl)ethan-1-amine).
Diampromide................................ 9615 I
Diethylthiambutene......................... 9616 I
Dimenoxadol................................ 9617 I
Dimepheptanol.............................. 9618 I
Dimethylthiambutene........................ 9619 I
Dioxaphetyl butyrate....................... 9621 I
Dipipanone................................. 9622 I
Ethylmethylthiambutene..................... 9623 I
Etonitazene................................ 9624 I
Etoxeridine................................ 9625 I
Furethidine................................ 9626 I
Hydroxypethidine........................... 9627 I
Ketobemidone............................... 9628 I
Levomoramide............................... 9629 I
Levophenacylmorphan........................ 9631 I
Morpheridine............................... 9632 I
Noracymethadol............................. 9633 I
Norlevorphanol............................. 9634 I
Normethadone............................... 9635 I
Norpipanone................................ 9636 I
Phenadoxone................................ 9637 I
Phenampromide.............................. 9638 I
Phenoperidine.............................. 9641 I
Piritramide................................ 9642 I
Proheptazine............................... 9643 I
Properidine................................ 9644 I
Racemoramide............................... 9645 I
Trimeperidine.............................. 9646 I
Phenomorphan............................... 9647 I
Propiram................................... 9649 I
[[Page 23048]]
1-Methyl-4-phenyl-4-propionoxypiperidine... 9661 I
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine................................... 9750 I
Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro- 9751 I
1Hbenzimidazol-1-yl)-N,N-diethylethan-1-
amine).
lunitazene (N,N-diethyl-2-(2-(4- 9756 I
fluorobenzyl)-5- nitro1H-benzimidazol-1-
yl)ethan-1- amine).
Metonitazene (N,N-diethyl-2-(2-(4- 9757 I
methoxybenzyl)-5- nitro-1Hbenzimidazol-1-
yl)ethan-1-amine.
N-pyrrolidino etonitazene; etonitazepyne (2- 9758 I
(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-
1-yl)ethyl)- 1Hbenzimidazole).
Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- 9759 I
propoxybenzyl)-1H-benzimidazol-1- yl)ethan-
1-amine).
Metodesnitazene (N,N-diethyl-2-(2-(4- 9764 I
methoxybenzyl)- 1H-benzimidazol-1-
yl)ethan-1-amine).
Etodesnitazene; etazene (2-(2-(4- 9765 I
ethoxybenzyl)- 1Hbenzimidazol-1-yl)-N,N-
diethylethan-1- amine).
Acryl fentanyl (N-(1-phenethylpiperidin-4- 9811 I
yl)-N-phenylacrylamide).
Para-Fluorofentanyl........................ 9812 I
3-Methylfentanyl........................... 9813 I
Alpha-methylfentanyl....................... 9814 I
Acetyl-alpha-methylfentanyl................ 9815 I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin- 9816 I
4-yl)propionamide.
Para-Methylfentanyl (N-(4-methylphenyl)-N- 9817 I
(1- phenethylpiperidin-4-yl)propionamide;
also known as 4- methylfentanyl).
4'-Methyl acetyl fentanyl (N-(1-(4- 9819 I
methylphenethyl)piperidin-4-yl)-N-
phenylacetamide).
ortho-Methyl methoxyacetyl fentanyl (2- 9820 I
methoxy-N-(2- methylphenyl)-N-(1-
phenethylpiperidin-4-yl)acetamide).
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821 I
yl)-N-phenylacetamide).
Butyryl Fentanyl........................... 9822 I
Para-fluorobutyryl fentanyl................ 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I
phenylacetamide.
Para-chloroisobutyryl fentanyl............. 9826 I
Isobutyryl fentanyl........................ 9827 I
Beta-hydroxyfentanyl....................... 9830 I
Beta-hydroxy-3-methylfentanyl.............. 9831 I
Alpha-methylthiofentanyl................... 9832 I
3-Methylthiofentanyl....................... 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4- 9834 I
yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl............................... 9835 I
Beta-hydroxythiofentanyl................... 9836 I
Para-methoxybutyryl fentanyl............... 9837 I
Ocfentanil................................. 9838 I
Thiofuranyl fentanyl (N-(1- 9839 I
phenethylpiperidin-4-yl)-Nphenylthiophene-
2-carboxamide; also known as 2-
thiofuranyl fentanyl; thiophene fentanyl).
Valeryl fentanyl........................... 9840 I
Phenyl fentanyl (N-(1-phenethylpiperidin-4- 9841 I
yl)-Nphenylbenzamide; also known as
benzoyl fentanyl).
beta'-Phenyl fentanyl (N-(1- 9842 I
phenethylpiperidin-4-yl)-N,3-
diphenylpropanamide; also known as [beta]'-
phenyl fentanyl; 3-phenylpropanoyl
fentanyl).
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Crotonyl fentanyl ((E-N-(1- 9844 I
phenethylpiperidin-4-yl)-N-phenylbut-2-
enamide).
Cyclopropyl Fentanyl....................... 9845 I
ortho-Fluorobutyryl fentanyl (N-(2- 9846 I
fluorophenyl)-N-(1- phenethylpiperidin-4-
yl)butyramide; also known as 2-
fluorobutyryl fentanyl).
Cyclopentyl fentanyl....................... 9847 I
ortho-Methyl acetylfentanyl (N-(2- 9848 I
methylphenyl)-N-(1- phenethylpiperidin-4-
yl)acetamide; also known as 2- methyl
acetylfentanyl).
Fentanyl related-compounds as defined in 21 9850 I
CFR 1308.11(h).
Fentanyl carbamate (ethyl (1- 9851 I
phenethylpiperidin-4-
yl)(phenyl)carbamate).
ortho-Fluoroacryl fentanyl (N-(2- 9852 I
fluorophenyl)-N-(1- phenethylpiperidin-4-
yl)acrylamide).
ortho-Fluoroisobutyryl fentanyl (N-(2- 9853 I
fluorophenyl)-N-(1- phenethylpiperidin-4-
yl)isobutyramide).
Para-Fluoro furanyl fentanyl (N-(4- 9854 I
fluorophenyl)-N-(1- phenethylpiperidin-4-
yl)furan-2-carboxamide).
2'-Fluoro ortho-fluorofentanyl (N-(1-(2- 9855 I
fluorophenethyl)piperidin-4-yl)-N-(2-
fluorophenyl)propionamide; also known as
2'-fluoro 2- fluorofentanyl).
beta-Methyl fentanyl (N-phenyl-N-(1-(2- 9856 I
phenylpropyl)piperidin-4-yl)propionamide;
also known as [beta]-methyl fentanyl).
meta-Fluorofentanyl (N-(3-fluorophenyl)-N- 9857 I
(1- phenethylpiperidin-4-yl)propionamide).
meta-Fluoroisobutylryl fentanyl (N-(3- 9858 I
fluorophenyl)-N-(1- phenethylpiperidin-4-
yl)isobutyramide).
para-Methoxyfuranyl fentanyl (N-(4- 9859 I
methoxyphenyl)-N- (1-phenethylpiperidin-4-
yl)furan-2-carboxamide).
3-Furanyl fentanyl (N-(1-phenethylpiperidin- 9860 I
4-yl)-Nphenylfuran-3-carboxamide).
2',5'-Dimethoxyfentanyl (N-(1-(2,5- 9861 I
dimethoxyphenethyl)piperidin-4-yl)-N-
phenylpropionamide).
Isovaleryl fentanyl (3-methyl-N-(1- 9862 I
phenethylpiperidin-4- yl)-N-
phenylbutanamide).
ortho-Fluorofuranyl fentanyl (N-(2- 9863 I
fluorophenyl)-N-(1- phenethylpiperidin-4-
yl)furan-2-carboxamide).
alpha'Methyl butyryl fentanyl (2-methyl-N- 9864 I
(1- phenethylpiperidin-4-yl)-N-
phenylbutanamide).
para-Methylcyclopropylfentanyl (N-(4- 9865 I
methylphenyl)-N- (1-phenethylpiperidin-4-
yl)cyclopropanecarboxamide).
Zipeprol (1-methoxy-3[-4-(2-methoxy-2- 9873 I
phenylethyl)piperazin-1-yl]-1-phenylpropan-
2-ol).
Phenmetrazine.............................. 1631 II
Methylphenidate............................ 1724 II
Amobarbital................................ 2125 II
Pentobarbital.............................. 2270 II
Secobarbital............................... 2315 II
Glutethimide............................... 2550 II
Dronabinol in an oral solution in a drug 7365 II
product approved for marketing by the U.S.
Food and Drug Administration.
[[Page 23049]]
Nabilone................................... 7379 II
1-Phenylcyclohexylamine.................... 7460 II
Phencyclidine.............................. 7471 II
ANPP (4-Anilino-N-phenethyl-4-piperidine).. 8333 II
Norfentanyl (N-phenyl-N-(piperidin-4-yl) 8366 II
propionamide).
Phenylacetone.............................. 8501 II
1-Piperidinocyclohexanecarbonitrile........ 8603 II
Alphaprodine............................... 9010 II
Anileridine................................ 9020 II
Coca Leaves................................ 9040 II
Cocaine.................................... 9041 II
Etorphine HCl.............................. 9059 II
Dihydrocodeine............................. 9120 II
Diphenoxylate.............................. 9170 II
Ecgonine................................... 9180 II
Ethylmorphine.............................. 9190 II
Levomethorphan............................. 9210 II
Levorphanol................................ 9220 II
Isomethadone............................... 9226 II
Meperidine................................. 9230 II
Meperidine intermediate-A.................. 9232 II
Meperidine intermediate-B.................. 9233 II
Meperidine intermediate-C.................. 9234 II
Metazocine................................. 9240 II
Oliceridine (N-[(3-methoxythiophen- 9245 II
2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-
oxaspiro[4.5] decan-9-yl] ethyl
{time{time} )amine fumarate).
Metopon.................................... 9260 II
Dextropropoxyphene, bulk (non-dosage forms) 9273 II
Dihydroetorphine........................... 9334 II
Opium tincture............................. 9630 II
Opium, powdered............................ 9639 II
Opium, granulated.......................... 9640 II
Noroxymorphone............................. 9668 II
Phenazocine................................ 9715 II
Thiafentanil............................... 9729 II
Piminodine................................. 9730 II
Racemethorphan............................. 9732 II
Racemorphan................................ 9733 II
Alfentanil................................. 9737 II
Remifentanil............................... 9739 II
Sufentanil................................. 9740 II
Carfentanil................................ 9743 II
Tapentadol................................. 9780 II
Bezitramide................................ 9800 II
Moramide-intermediate...................... 9802 II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances to support research activities funded by the
National Institute on Drug Abuse. No other activities for these drug
codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-07037 Filed 4-2-24; 8:45 am]
BILLING CODE P
